Publication: Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study
Loading...
Date
2023
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
FRONTIERS MEDIA SA
Abstract
The MET exon 14 skipping (METex14) mutation is an important oncogenic driver in lung cancer. We performed a retrospective analysis of clinical data from lung cancer patients with the METex14 mutation to analyze their survival outcomes and associated prognostic factors.
Description
Keywords
MET exon 14 skipping; adenocarcinoma; immunohistochemistry; overall survival; pulmonary sarcomatoid carcinoma